60 Degrees Pharmaceuticals Inc (SXTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 126 | 146 | 43 | 127 | 63 |
| Cost of Goods | 90 | 65 | 146 | 71 | 184 |
| Gross Profit | 36 | 81 | -104 | 56 | -121 |
| Operating Expenses | 4,315 | 1,478 | 1,937 | 1,649 | 851 |
| Operating Income | -4,189 | -1,332 | -1,894 | -1,522 | -788 |
| Interest Expense | 4 | 1 | 5 | 40 | 1,100 |
| Other Income | 19 | 1,761 | -147 | 5,736 | -1,456 |
| Pre-tax Income | -4,174 | 428 | -2,046 | 4,174 | -3,344 |
| Net Income Continuous | -4,174 | 428 | -2,046 | 4,174 | -3,344 |
| Minority Interests | -2 | -3 | -34 | -10 | -7 |
| Net Income | $-4,173 | $431 | $-2,012 | $4,183 | $-3,337 |
| EPS Basic Total Ops | -4.23 | 0.36 | 9.28 | 9.24 | -16.84 |
| EPS Basic Continuous Ops | -4.11 | 0.51 | 9.44 | 9.42 | -16.89 |
| EPS Diluted Total Ops | -4.23 | 0.36 | 9.28 | 9.24 | -16.84 |
| EPS Diluted Continuous Ops | -4.11 | 0.51 | 9.44 | 9.42 | -16.89 |
| EPS Diluted Before Non-Recurring Items | -4.23 | 0.36 | -5.28 | -3.60 | -16.81 |
| EBITDA(a) | $-1,425 | $-1,184 | $-1,566 | $-1,313 | $-215 |